BIMI Medical PE Ratio 2010-2023 | BIMI
Current and historical p/e ratio for BIMI Medical (BIMI) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. BIMI Medical PE ratio as of March 18, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
BIMI Medical PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-03-15 | 2.81 | 0.00 | |
2023-09-30 | 1.57 | $-0.51 | 0.00 |
2023-06-30 | 1.40 | $-1.60 | 0.00 |
2023-03-31 | 0.55 | $-3.63 | 0.00 |
2022-12-31 | 1.23 | $-6.10 | 0.00 |
2022-09-30 | 2.84 | $-6.10 | 0.00 |
2022-06-30 | 6.39 | $-7.50 | 0.00 |
2022-03-31 | 13.80 | $-6.20 | 0.00 |
2021-12-31 | 25.50 | $-13.50 | 0.00 |
2021-09-30 | 35.95 | $-13.50 | 0.00 |
2021-06-30 | 67.00 | $-20.00 | 0.00 |
2021-03-31 | 87.50 | $3.50 | 25.00 |
2020-12-31 | 83.50 | $1.50 | 55.67 |
2020-09-30 | 84.00 | $1.50 | 56.00 |
2020-06-30 | 113.50 | $7.50 | 15.13 |
2020-03-31 | 124.00 | $-21.00 | 0.00 |
2019-12-31 | 159.50 | $-9.00 | 0.00 |
2019-09-30 | 54.50 | $-9.00 | 0.00 |
2019-06-30 | 118.50 | $-7.50 | 0.00 |
2019-03-31 | 310.00 | $-13.00 | 0.00 |
2018-12-31 | 786.50 | $-16.50 | 0.00 |
2018-09-30 | 235.00 | $-20.00 | 0.00 |
2018-06-30 | 134.00 | $-21.00 | 0.00 |
2018-03-31 | 71.00 | $-12.00 | 0.00 |
2017-12-31 | 48.50 | $-13.50 | 0.00 |
2017-09-30 | 46.50 | $-13.00 | 0.00 |
2017-06-30 | 45.50 | $-12.00 | 0.00 |
2016-12-31 | 43.26 | $-14.00 | 0.00 |
2016-09-30 | 57.50 | $-15.00 | 0.00 |
2016-06-30 | 37.45 | $-12.00 | 0.00 |
2016-03-31 | 37.05 | $-11.00 | 0.00 |
2015-12-31 | 36.50 | $-8.00 | 0.00 |
2015-09-30 | 61.50 | $-6.00 | 0.00 |
2015-06-30 | 77.50 | $-3.00 | 0.00 |
2015-03-31 | 87.50 | $-5.50 | 0.00 |
2014-12-31 | 79.50 | $-5.50 | 0.00 |
2014-09-30 | 140.13 | $-4.50 | 0.00 |
2014-06-30 | 132.50 | $-9.50 | 0.00 |
2014-03-31 | 80.00 | $-6.00 | 0.00 |
2017-03-31 | 55.00 | $-4.50 | 0.00 |
2013-12-31 | 79.50 | $-1.50 | 0.00 |
2013-09-30 | 94.00 | $1.50 | 62.67 |
2013-06-30 | 31.95 | $1.50 | 21.30 |
2013-03-31 | 41.50 | $1.00 | 41.50 |
2012-12-31 | 50.86 | $12.00 | 4.24 |
2012-06-30 | 57.50 | $11.50 | 5.00 |
2012-03-31 | 47.00 | $16.00 | 2.94 |
2011-12-31 | 33.30 | $18.50 | 1.80 |
2011-09-30 | 38.05 | $12.00 | 3.17 |
2011-06-30 | 82.78 | $11.50 | 7.20 |
2011-03-31 | 163.01 | $26.00 | 6.27 |
2010-12-31 | 250.53 | $23.50 | 10.66 |
2012-09-30 | 34.55 | $19.00 | 1.82 |
2010-09-30 | 325.00 | $19.00 | 17.11 |
2010-06-30 | 318.75 | 0 | 0.00 |
2010-03-31 | 500.00 | 0 | 0.00 |
2009-12-31 | 525.00 | 0 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.033B | $0.012B |
BIMI International Medical Inc. is a healthcare product and services provider as well as operates private hospitals principally in China. BIMI International Medical Inc., formerly known as BOQI International Medical Inc., is based in NEW YORK. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $119.394B | 15.50 |
Cencora (COR) | United States | $47.523B | 18.97 |
ICON (ICLR) | Ireland | $27.616B | 27.24 |
DiDi Global (DIDIY) | China | $18.703B | 0.00 |
Avantor (AVTR) | United States | $17.011B | 23.44 |
Viatris (VTRS) | United States | $14.324B | 4.09 |
CochLear (CHEOY) | $14.284B | 0.00 | |
Charles River Laboratories (CRL) | United States | $13.285B | 24.32 |
Revvity (RVTY) | United States | $12.958B | 22.56 |
Medpace Holdings (MEDP) | United States | $12.204B | 44.68 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $11.925B | 0.00 |
Natera (NTRA) | United States | $10.810B | 0.00 |
HealthEquity (HQY) | United States | $6.988B | 61.70 |
Amplifon S.p.A (AMFPF) | Italy | $6.762B | 34.33 |
Bausch + Lomb (BLCO) | Canada | $5.598B | 21.55 |
Doximity (DOCS) | United States | $5.201B | 38.72 |
Organon (OGN) | United States | $4.673B | 4.52 |
Sotera Health (SHC) | United States | $4.107B | 20.17 |
Surgery Partners (SGRY) | United States | $3.605B | 33.49 |
Progyny (PGNY) | United States | $3.394B | 56.73 |
Life Times (LTH) | United States | $2.779B | 30.72 |
GoodRx Holdings (GDRX) | United States | $2.729B | 138.20 |
Premier (PINC) | United States | $2.532B | 9.27 |
Teladoc Health (TDOC) | United States | $2.526B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $2.225B | 7.20 |
Agilon Health (AGL) | United States | $2.179B | 0.00 |
NovoCure (NVCR) | Jersey | $1.497B | 0.00 |
BrightSpring Health Services (BTSG) | United States | $1.411B | 0.00 |
Agiliti (AGTI) | United States | $1.351B | 22.13 |
Establishment Labs Holdings (ESTA) | $1.333B | 0.00 | |
Alignment Healthcare (ALHC) | United States | $0.943B | 0.00 |
Pediatrix Medical (MD) | United States | $0.797B | 8.24 |
Embecta (EMBC) | United States | $0.762B | 5.03 |
COMPASS Pathways (CMPS) | United Kingdom | $0.613B | 0.00 |
InnovAge Holding (INNV) | United States | $0.583B | 0.00 |
Enhabit (EHAB) | United States | $0.552B | 50.04 |
CareDx (CDNA) | United States | $0.525B | 0.00 |
Beauty Health (SKIN) | United States | $0.474B | 0.00 |
MultiPlan (MPLN) | United States | $0.457B | 0.00 |
ModivCare (MODV) | United States | $0.415B | 5.50 |
QDM (QDMI) | Hong Kong, SAR China | $0.408B | 10.69 |
LifeMD (LFMD) | United States | $0.407B | 0.00 |
DocGo (DCGO) | United States | $0.381B | 61.00 |
Sharecare (SHCR) | United States | $0.345B | 0.00 |
GeneDx Holdings (WGS) | United States | $0.313B | 0.00 |
Sera Prognostics (SERA) | United States | $0.290B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.240B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.214B | 0.00 |
Biodesix (BDSX) | United States | $0.143B | 0.00 |
Oncology Institute (TOI) | United States | $0.124B | 0.00 |
So-Young (SY) | China | $0.100B | 25.00 |
Pono Capital Two (PTWO) | United States | $0.067B | 0.00 |
Nutex Health (NUTX) | United States | $0.065B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.047B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.037B | 0.00 |
TRxADE HEALTH (MEDS) | United States | $0.035B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.033B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
OncoCyte (OCX) | United States | $0.025B | 0.00 |
DermTech (DMTK) | United States | $0.024B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.013B | 0.00 | |
Aesthetic Medical Hldngs Group (AIH) | China | $0.010B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
XWELL (XWEL) | United States | $0.008B | 0.00 |
OpGen (OPGN) | United States | $0.005B | 0.00 |
Assure Holdings (IONM) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.001B | 0.00 |